|
Facebook
Twitter
Linkedin
|
Definiens AG
About Definiens AG
By automating time-consuming image analysis processes, Definiens supports healthcare providers in analyzing and interpreting vast numbers of digital images accurately and consistently. Definiens improves the analysis of tissue samples and non-invasive imaging, enabling translational medicine - from early diagnosis to personalized treatment.
At the core of Definiens software applications and solutions is the patented Definiens Cognition Network Technology®, modeled on the human cognitive perception process. Instead of examining an image pixel by pixel, it recognizes groups of pixels as objects, picking out shapes, colors and textures. The technology analyzes the relationships between objects of interest to make intelligent inferences. Definiens software applications build on this technology and are ideally suited to screen, identify, diagnose and assist in the treatment of cancer.
Definiens™ software can compare images from different modalities, over time, and in a consistent and reproducible manner. It supports radiologists and other medical experts in the collection of diagnostic data, which reduces human error due to fatigue or data overload. Definiens software applications provide automated volumetric quantification of almost all structures, including organs and lesions and can be integrated with standard medical imaging systems. Definiens provides image intelligence along the entire healthcare value chain, from screening to treatment and follow-up imaging.
Definiens AG Details
Company Name
Definiens AGAddress
Trappentreustrasse 1, 80339 MunichHeadquarters City
Munich, GermanyFounded
1994Country of Incorporation
GermanyWe'll be at:
Product Areas
Definiens AG News
- Karmanos Cancer Institute Uses Definiens Tissue Studio for Biomarker Development
- Definiens Collaborates with Charité Berlin to Develop New Pathology Software for Breast Cancer Diagnosis and Treatment
- Definiens Tissue Studio 2.0 Supports Tumor Profiling, Multiplexing and Biomarker Translational Research
- Trimble Acquires Definiens' Earth Sciences Business to Expand Its GeoSpatial Portfolio
- Definiens to Present Image Analysis Software for Clinical Trials and Translational Research at ASCO Meeting 2010
- Definiens Digital Pathology Software Utilized for Hamner Institutes Liver Toxicology Study
- Definiens & Philips Join Hands in Digital Pathology
- Volumetric Image Analysis Promotes Accurate Assessment of Patient Response to Cancer Treatment
- Visage Imaging and Definiens Announce Partnership
- Definiens Unveils Definiens LymphExpert 2.0








